RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking preclinical research that supports a nearly ...

Intellia Therapeutics paused dosing and screening in its MAGNITUDE and MAGNITUDE-2 Phase 3 trials after a patient experienced a serious liver-related reaction. This decision led to a steep decline in ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...

Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was hospitalized with liver damage.

Because the new method can replace a large stretch of defective DNA with a healthy sequence, the same retron-based package can fix any combination of mutations within that stretch of DNA without ...

How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...

Traditional breeding and genetic modification methods have struggled to keep pace with the rapid evolution of plant viruses.

Precision Biosciences (($DTIL)) announced an update on their ongoing clinical study. Precision BioSciences is conducting a Phase 1 study titled ‘A ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Baby KJ's medical team intend to ask the FDA to start a clinical trial that would be open to patients with seven different ...

Researchers have identified molecular mechanisms behind age-related memory decline — and shown they can be reversed.

As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...